Empirical therapy advisor
Before culture results are back: how likely is each antibiotic to cover the pathogen of a patient like this one, in this ward, given the last 12 months of results and today's alerts.
Based on 1260 first isolates · PHC-S · Cystitis (lower UTI) · 2024-08-11 → 2025-08-10
Health centre SouthNarrowest option reaching 80 % coverage, no active warning
nitrofurantoin 81 % (79 %–83 %)
No tissue or blood levels: cystitis only.
Not covered: Proteus mirabilis (8 %), Pseudomonas aeruginosa (5 %), Klebsiella pneumoniae (4 %)
AntibioticCoverage, 12 months (95 % CI)12 mo4 wk
⚠ CPE case in the ward: carbapenem resistance possible
81 %
80 %
n = 137
Most likely organisms for this profile
Escherichia coli
48 %
Klebsiella pneumoniae
14 %
Enterococcus faecalis
12 %
Proteus mirabilis
8 %
Pseudomonas aeruginosa
5 %
Staphylococcus aureus
4 %
Decision support only: coverage is the share of first isolates from similar patients that were susceptible (an organism not tested for a drug counts as not covered). It does not replace local treatment guidelines, allergy and severity assessment, or clinical judgement. The black tick on each bar is the coverage target; the bracket is the 95 % confidence interval.